Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma

ConditionInfantile Hemangioma

Trial statusRecruiting

Trial phasePhase 2, Phase 3

Trial typeInterventional

Biological sexAll

Age1-4

SponsorWest China Hospital

About this trial

The main objective of this study was to determine the efficacy of different doses of propranolol in the treatment of ulcerattion infantile hemangioma (IH).

Eligibility criteria

Qualifiers

all patients with ulcer IH;

children with ulcer IH treated with propranolol.

Disqualifiers

None

Trial design

Treatments tested in this trial

propranolol

Treatment groups

24 Participants

are divided into 2 treatment groups

Sponsors and collaborators

West China Hospital

Lead sponsor

Source ClinicalTrials.gov